We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Novavax Inc | NASDAQ:NVAX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.21 | -4.41% | 4.55 | 4.54 | 4.61 | 4.94 | 4.475 | 4.94 | 5,271,344 | 00:43:38 |
Prior to joining Novavax, she was Senior Director, Quality at PharmAthene from 2005 until 2011, where she managed that company’s global QA/QC activities. Her prior experience includes quality assurance positions of increasing responsibility in a number of companies including Baxter, Shire and BioReliance. Ms. Lichaa received her B.S. in Toxicology from Northeastern University.
“Jody has successfully developed and managed a talented quality assurance team that has been instrumental in the ongoing development of our vaccine candidates,” said Stanley C. Erck, President and CEO. “Jody’s talent and expertise will continue to be critical as we prepare for Phase 3 development of our RSV F Vaccines.”
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. Additional information about Novavax is available on the Company's website, novavax.com.
Contact: Novavax, Inc. Barclay A. Phillips SVP, Chief Financial Officer and Treasurer Andrea N. Flynn, Ph.D. Senior Manager, Investor Relations ir@novavax.com 240-268-2000 Russo Partners, LLC David Schull Todd Davenport, Ph.D. david.schull@russopartnersllc.com todd.davenport@russopartnersllc.com 212-845-4271
1 Year Novavax Chart |
1 Month Novavax Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions